Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: Effect of human platelet antigen mismatch on platelet engraftment and graft-versus-host disease

Transfusion

Volumn 44, Issue 5, 2004, Pages 771-776

  Garcia Malo M D ^b   Corral, Javier ^a   Gonzalez M ^b   Solano, C ^b   Gonzalez Conejero R ^b   Caballero, M D ^b   Perez R ^b   Moraleda, J M ^b   Vicente, V ^b  

^a HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN PLATELET ANTIGEN 1; HUMAN PLATELET ANTIGEN 2; HUMAN PLATELET ANTIGEN 5; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP SYSTEM; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN PLATELET ANTIGEN MISMATCH; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PLATELET ANTIGEN SYSTEM; PREGNANCY; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANTIGENS, HUMAN PLATELET; FEMALE; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLATELET TRANSFUSION; TRANSPLANTATION, HOMOLOGOUS;

EID: 2342550543     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03190.x     Document Type: Article

References (31)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-38.
2. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A. Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 2001;27:899-916.
3. Sullivan KM. Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SS, eds. Hematopoietic cell transplantation. 2nd ed. Boston: Blackwell Science, 1999:515-636.
4. Simpson E, Scott D, James E, et al. Minor H antigens: genes and peptides. Transpl Immunol 2002;10:115-23.
5. Rozman P. Platelet antigens: the role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transpl Immunol 2002;10:165-81.
6. Panzer S, Kiefel V, Bartram CR, et al. Immune thrombocytopenia more than a year after allogeneic marrow transplantation due to antibodies against donor platelets with anti-P1A1 specificity: evidence for a host-derived immune reaction. Br J Haematol 1989;71:259-64.
7. Taaning E, Jacobsen N, Morling N. Graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. Br J Haematol 1994;86:651-3.
8. Taaning E, Jacobsen N. Platelet transfusion refractoriness due to graft-derived anti-HPA-2b production after allogeneic bone-marrow transplantation. Transplant Proc 1994; 26:1826.
9. Wernet D, Northoff H, Schnaidt M. Reactivation of antibodies of donor and recipient origin to platelet antigens early after allogeneic bone marrow transplantation: a case report. Br J Haematol 1994;88:615-7.
10. Bierling P, Pignon JM, Kuentz M, et al. Thrombocytopenia after bone marrow transplantation caused by a recipient origin Br (a) allo-antibody: presence of mixed chimerism 3 years after the graft without hematologic relapse. Blood 1994;83:274-9.
11. Evenson DA, Stroncek DF, Pulkrabek S, et al. Posttransfusion purpura following bone marrow transplantation. Transfusion 1995;35:688-93.
12. Kieffer N, Phillips DR. Platelet membrane glycoproteins: functions in cellular interactions. Annu Rev Cell Biol 1990; 6:329-57.
13. Pigott R, Power C. The adhesion molecule facts book. London: Academic Press, 1993.
14. Giltay JC, von Brinkman HJ, dem Borne AE, van Mourik JA. Expression of the alloantigen Zwa (or P1A1) on human vascular smooth muscle cells and foreskin fibroblasts: a study on normal individuals and a patient with Glanzmann's thrombasthenia. Blood 1989;74:965-70.
15. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA. Tumor necrosis factor-alpha modulation of glycoprotein Ib alpha expression in human endothelial and erythroleukemia cells. Blood 1992;80:153-61.
16. Giltay JC, Brinkman HJ, von Modderman PW, et al. Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complex. Blood 1989;73: 1235-41.
17. Shaw S, Luce GG, Gilks WR, et al. Leucocyte differentiation antigen database. In: Schlossman SF, Boumsell L, Gilks W, et al, eds. New York: Oxford University Press, 1995:16-98.
18. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18:295-304.
19. Corral J, González-Conejero R, Rivera J, et al. HPA-1 genotype in arterial thrombosis: role of HPA-1b polymorphism in platelet function. Blood Coagul Fibrinolysis 1997;8:284-90.
20. González-Conejero R, Lozano ML, Rivera J, et al. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998;92: 2771-6.
21. 2 gene in platelet GP Ia collagen receptor expression and function: effect in thromboembolic diseases. Thromb Haemost 1999;81:951-6.
22. Valentin N, Vergracht A, Bignon JD, et al. DRw52a is involved in alloainmunization against PL-A1 antigen. Human Immunol 1990;27:73-9.
23. L'Abbe D, Tremblay L, Filion M, et al. Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201. Hum Immunol 1992;34:107-14.
24. Kuijpers RW, dem Borne AE, Kiefel V, et al. Leucine33-proline33 substitution in human platelet glycoprotein IIIa determines HLA-DRw52a (Dw24) association of the immune response against HPA-1a (Zwa/PIA1) and HPA-1b (Zwb/PIA2). Hum Immunol 1992;34:253-6.
25. Kekomaki S, Kyllonen L, Salmela K, et al. Platelet-specific alloantigens in cadaveric renal transplantation: a prospective study. Effect of HPA-5b mismatch in acute vascular rejection of renal allografts. Tissue Antigens 2001;57:154-7.
26. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001;97: 3390-400.
27. Maruya E, Saji H, Seki S, et al. Evidence that CD31, CD49b, and CD62L are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants. Blood 1998;92:2169-76.
28. Juji T, Watanabe Y, Ishikawa Y, et al. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation. Tissue Antigens 1999;54:229-34.
29. Corral J, Gonzalez-Conejero R, Lozano ML, et al. New alleles of the platelet glycoprotein Ibalpha gene. Br J Haematol 1998;103:997-1003.
30. Balduini CL, Frassoni F, Noris P, et al. Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. Br J Haematol 2001;114: 951-3.
31. Goulmy E, Schipper R, Pool J, et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med 1996;334:281-5.